DrugPatentWatch Database Preview
Details for Patent: 9,962,338
» See Plans and Pricing
Which drugs does patent 9,962,338 protect, and when does it expire?
Patent 9,962,338 protects SEEBRI and UTIBRON and is included in two NDAs.
This patent has two hundred and twenty-nine patent family members in thirty-six countries.
Summary for Patent: 9,962,338
| Title: | Method of making particles for use in a pharmaceutical composition |
| Abstract: | The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the presence of particles of an additive material which is suitable for the promotion of the dispersal of the composite active particles upon actuation of an inhaler. The invention also relates to compositions for inhalation prepared by the method. |
| Inventor(s): | Staniforth; John Nicholas (Wiltshire, GB), Green; Matthew Michael (Wiltshire, GB), Morton; David Alexander Vodden (Wiltshire, GB) |
| Assignee: | VECTURA LIMITED (Chippenham, Wiltshire, GB) |
| Application Number: | 15/079,171 |
|
Patent Claim Types: see list of patent claims | Composition; Delivery; |
Drugs Protected by US Patent 9,962,338
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | SEEBRI | glycopyrrolate | POWDER;INHALATION | 207923-001 | Oct 29, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Novartis | UTIBRON | glycopyrrolate; indacaterol maleate | POWDER;INHALATION | 207930-001 | Oct 29, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,962,338
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0029261.5 | Nov 30, 2000 |
| United Kingdom | 0030946.8 | Dec 19, 2000 |
| PCT/GB01/01606 | Apr 9, 2001 | |
| United Kingdom | 0124010.0 | Oct 5, 2001 |
International Family Members for US Patent 9,962,338
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 330585 | Start Trial | |||
| Austria | 339195 | Start Trial | |||
| Austria | 348603 | Start Trial | |||
| Austria | 364381 | Start Trial | |||
| Austria | 377416 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
